Table 2 Main characteristics of study sample
n (n/%) | 118 (100%) |
Gender (M/F) (n/%) | 56 / 62 (47.5/52.5%) |
Age at diagnosis (years) | 33.9 ± 16.0 |
Age (years) | 52.4 ± 13.9 |
Weight (Kg) | 74.3 ± 15.5 |
Height (Cm) | 165.4 ± 10.1 |
BMI (Kg/m 2 ) | 27.1 ± 4.8 |
Waist circumference (M/F) (cm) | 99.5 ± 12.9 / 90.8 ± 13.2 |
Obesity (n/%) | 31 (26.3%) |
Smoking habit (n/%) | 39 (33.1%) |
Hypertension (n/%) | 31 (26.3%) |
Diabetes (n/%) | 9 (7.6%) |
Prediabetes (n/%) | 52 (44.1%) |
Prediabetes regional criteria (n/%) | 26 (22.0%) |
CVD (n/%) | 23 (19.5%) |
Statin treatment (n/%) | 110 (93.2%) |
Ezetimibe treatment (n/%) | 75 (63.6%) |
Statin-Ezetimibe combination (n/%) | 74 (62.7%) |
iPSCK9 (n/%) | 6 (5.1%) |